Piper Sandler Downgrades Repro Med Systems (KRMD) to Neutral

Piper Sandler analyst Matthew O'Brien downgraded Repro Med Systems (NASDAQ: KRMD) from Overweight to Neutral with a price target of $4.50 (from $9.00).

For an analyst ratings summary and ratings history on Repro Med Systems click here. For more ratings news on Repro Med Systems click here.

Shares of Repro Med Systems closed at $5.18 yesterday.

You May Also Be Interested In

• Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Lordstown Motors, Root, Vroom, and Repro Med and Encourages Investors to Contact the Firm
• Origin Energy Ltd. (ORG:AU) (OGFGY) PT Lowered to AUD6.50 at Goldman Sachs
• First Financial Holding Co Ltd (2892:TT) PT Raised to TWD18.16 at Goldman Sachs